Caribou Biosciences CFO Jason O’Byrne resigns

In a regulatory filing, the company disclosed that on September 1, Jason O’Byrne, CFO of Caribou Biosciences, informed the company of his intent to resign from his position, effective September 27, to pursue another opportunity. O’Byrne’s resignation is not the result of any disagreement with the company on any matter related to the company’s financial reporting or accounting policies, procedures, estimates, or judgments. The company has initiated a search for a new CFO. The company intends to appoint Ryan Fischesser, the company’s current VP of Finance and Controller, to assume the role of the company’s principal accounting officer, effective as of the close of business on September 27. Fischesser had previously served as the company’s principal accounting officer from the time of the company’s initial public offering through December 15, 2022.